Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 10/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | TDO2 | P48775 | 1/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 4/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 4/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3618046 | 0.81 | KDM4E (0.63) | ALDH1A1CYP3A4CYP1A2SMN1; SMN2HSD17B10 | |
| SCHEMBL136631 | 0.78 | NOTUM (0.61) | ALDH1A1CYP1A2TDO2NOTUMSMN1; SMN2 | |
| SCHEMBL9768763 | 0.74 | NOTUM (0.77) | ALDH1A1CYP1A2NOTUMSMN1; SMN2KDM4E | |
| SCHEMBL30238423 | 0.74 | NOTUM (0.63) | ALDH1A1CYP1A2NOTUMSMN1; SMN2HSD17B10 | |
| SCHEMBL120088 | 0.74 | CYP2A6 (1.00) | CYP2A6ALDH1A1CYP3A4CYP1A2SMN1; SMN2 | |
| SCHEMBL29419014 | 0.74 | CYP2A6 (1.00) | CYP2A6ALDH1A1CYP3A4CYP1A2SMN1; SMN2 | |
| SCHEMBL30473120 | 0.74 | CYP2A6 (1.00) | CYP2A6ALDH1A1CYP3A4CYP1A2SMN1; SMN2 | |
| SCHEMBL11020717 | 0.73 | NOTUM (0.61) | ALDH1A1CYP1A2NOTUMSMN1; SMN2KDM4E | |
| SCHEMBL3195754 | 0.73 | — | — | |
| SCHEMBL21408748 | 0.72 | NOTUM (0.50) | ALDH1A1CYP1A2NOTUMSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758896-A1 | PYRIDINYL-ISOXAZOLES AND THEIR USE AS HERBICIDES | Bayer CropScience GmbH (DE) | 2007-03-07 | — | — | EP | disclosed |
| WO-2005123726-A1 | PYRIDINYL-ISOXAZOLES AND THEIR USE AS HERBICIDES | BAYER CROPSCIENCE GMBH (DE) | 2005-12-29 | — | — | WO | disclosed |
| US-20050282707-A1 | Pyridinylisoxazoles and their use as herbicides | BAYER CROPSCIENCE GMBH (DE) | 2005-12-22 | — | — | US | disclosed |
| US-6927228-B2 | Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2005-08-09 | — | — | US | disclosed |
| US-20040039038-A1 | Biaromatic compound activators of PPARy-type receptors | GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) | 2004-02-26 | — | — | US | disclosed |
| US-5356912-A | 3-(5-isoxazolyl)-1-methyl-1,2,3,6-tetrahydropyridine useful for treating Alzheimer's disease | NOVO NORDISK A/S (DK) | 1994-10-18 | — | — | US | disclosed |
| US-5262427-A | Cognition activators for Alzheimer*s disease | NOVO NORDISK A/S (DK) | 1993-11-16 | — | — | US | disclosed |
| EP-0316718-A2 | Azacyclic compounds and their preparation and use | NOVO NORDISK A/S (DK) | 1989-05-24 | — | — | EP | disclosed |
| CN-85105299-A | The preparation method of cephem compounds | — | 1987-01-07 | — | — | CN | disclosed |
| EP-0160969-A2 | Cephem compounds | Takeda Chemical Industries, Ltd. (JP) | 1985-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039038-A1 | Biaromatic compound activators of PPARy-type receptors | PPARG, PPARA, PPARD | CYP2A6 156/4885ALDH1A1 378/4885CYP3A4 479/4885 |
| US-20050282707-A1 | Pyridinylisoxazoles and their use as herbicides | PRDX1, CYP4X1, PRDX4 | CYP2A6 142/4885ALDH1A1 238/4885CYP3A4 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.